Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04619823

Virological and Immunological Determinants of Arbovirus Infection in New Caledonia

Led by Institut Pasteur · Updated on 2024-05-23

250

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

Sponsors

I

Institut Pasteur

Lead Sponsor

I

Institut Pasteur de Nouvelle-Calédonie

Collaborating Sponsor

AI-Summary

What this Trial Is About

Arboviruses, diseases transmitted to humans by the bite of an insect vector, are a major public health problem, particularly in tropical and sub-tropical countries. In New Caledonia, dengue epidemics are recurrent and may be associated with the co-circulation of other arboviruses such as Zika or chikungunya. The virological determinants which condition the occurrence of these epidemics may be linked to an increased vectorial competence of the vector mosquito Aedes aegypti for a particular viral isolate. In fact, the Aedes aegypti mosquito is infected by making a blood meal on a person infected with an arbovirus. The virus infects its digestive tract, then spreads throughout the mosquito's body until it reaches its salivary glands. The virus is then present in the saliva and will be injected into the human host during a new blood meal. Some viral variants are best transmitted by Aedes aegypti. In general, the study of this vectorial competence is carried out by experiments in the laboratory during which an artificial blood meal composed of mammalian blood (human, rabbit, etc.) is mixed with a viral stock. Carrying out deported blood meals during which blood collected from patients infected with an arbovirus is used to gorge mosquitoes makes it possible to place oneself in experimental conditions as close as possible to the natural cycle of transmission of arboviruses. In the human host, cells of the myeloid lineage present in the peripheral blood constitute preferred targets of replication for arboviruses. At the same time, the peripheral blood cells of patients are activated in response to infection and secrete many soluble factors released into the blood of patients. The study of blood samples from patients infected with arboviruses is therefore of prime importance for understanding both the replicative mechanisms of arboviruses but also the immune response they induce.

CONDITIONS

Official Title

Virological and Immunological Determinants of Arbovirus Infection in New Caledonia

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patient
  • Patient showing clinical signs suggestive of an arbovirus infection, including fever and at least two symptoms such as muscle pain, retro-orbital pain, low platelets (if available), digestive symptoms
  • Symptoms started within 7 days prior to blood sample collection
  • Patient informed about the study and biological sample collection
  • Patient has given consent for data collection and use of an additional blood sample
Not Eligible

You will not qualify if you...

  • Patient with another known viral infection, inflammatory disease, or using anti-inflammatory drugs
  • Pregnant patient
  • Patient who traveled abroad within 15 days before symptoms began
  • Incomplete or unavailable blood sample
  • Patient condition deemed unsuitable by the doctor for the additional blood sample
  • Patient who has not consented to participate in the research

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centre Hospitalier Territorial de Nouvelle-Calédonie

Dumbéa Sur Mer, New Caledonia

Actively Recruiting

Loading map...

Research Team

M

Myrielle Dupont-Rouzeyrol, PhD

CONTACT

C

Catherine Inizan, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here